BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7286183)

  • 1. [Psychotropic activity of thiaisochromane derivatives].
    Val'dman AV; Shmidt Iu; Kozlovskaia MM; Andreas K; Fisher Kh
    Farmakol Toksikol; 1981; 44(3):270-5. PubMed ID: 7286183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectra of psychotropic activity and neurochemical mechanisms of action of bi- and tetracyclic antidepressants.
    Kozlovskaya MM; Avdulov NA; Kushnaryov VV
    Ann Ist Super Sanita; 1982; 18(1):83-6. PubMed ID: 6133492
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
    Boksay IJ; Popendiker K; Weber RO; Söder A
    Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic activity of pyrimidoindole derivatives].
    Artemenko GN; Vikhliaev IuI; Kucherova NF; Borisova LN
    Farmakol Toksikol; 1976; 39(6):651-5. PubMed ID: 1088263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of the effect of psychotropic preparations on the synaptosomal uptake of monoamines].
    Maĭsov NI; Gankina EM; Voronina TA
    Farmakol Toksikol; 1985; 48(4):46-50. PubMed ID: 4043363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialkyl- [2-(1-oxa-3,4,9-triaza-fluoren-2-yl-methoxy)ethyl] amines on biogenic amines: new potential antidepressants.
    Venkatesham A; Rao JV; Kumar KV; Sarangapani M; Devarakonda K
    Can J Physiol Pharmacol; 2012 Dec; 90(12):1585-90. PubMed ID: 23210437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 10. [New psychotropic agents. I. Synthesis and pharmacologic activity of derivatives of 5H-imidazo-[2,1-c][1,4]benzodiazepine].
    Stefancich G; Artico M; Corelli F; Silvestri R; de Feo G; Mazzanti G; Durando L; Palmery M
    Farmaco Sci; 1985 Jun; 40(6):429-41. PubMed ID: 4029388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin.
    Yi LT; Li JM; Li YC; Pan Y; Xu Q; Kong LD
    Life Sci; 2008 Mar; 82(13-14):741-51. PubMed ID: 18308340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attempted neurochemical interpretation of natural behavior and behavior modified by neuroleptics].
    Procopiu-Constantinescu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(2):81-8. PubMed ID: 1081266
    [No Abstract]   [Full Text] [Related]  

  • 14. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of antidepressant drugs.
    Hamon M
    Adv Biosci; 1978 Jul 24-25; 21():117-28. PubMed ID: 385392
    [No Abstract]   [Full Text] [Related]  

  • 17. Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test?
    Renard CE; Dailly E; Nic Dhonnchadha BA; Hascoet M; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1255-9. PubMed ID: 15588751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRL 13776: a novel antihypertensive agent with interesting monoamine depleting properties.
    Melrose J; Palfreyman MG; Poyser RH; Whiting RL
    Br J Pharmacol; 1977 Nov; 61(3):357-69. PubMed ID: 588803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the mechanism of therapeutic actions of psychotropic drugs (author's transl)].
    Mroji T
    No To Shinkei; 1979 Nov; 31(11):1075-97. PubMed ID: 43160
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of psychotropic substances on the deamination of monoamines in the rat brain].
    Gol'dina OA; Gankina EM
    Farmakol Toksikol; 1988; 51(4):22-5. PubMed ID: 3191966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.